Genetic Susceptibility to Bortezomib-Induced Peripheral Neuroropathy: Replication of the Reported Candidate Susceptibility Loci
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genetic Susceptibility to Bortezomib-Induced Peripheral Neuroropathy: Replication of the Reported Candidate Susceptibility Loci
Authors
Keywords
GWAS, Bortezomib, Multiple myeloma, Peripheral neuropathy, Neurotoxicity
Journal
NEUROCHEMICAL RESEARCH
Volume 42, Issue 3, Pages 925-931
Publisher
Springer Nature
Online
2016-07-16
DOI
10.1007/s11064-016-2007-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PSMB4 promotes multiple myeloma cell growth by activating NF-κB-miR-21 signaling
- (2015) Peihao Zheng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
- (2015) E. Terpos et al. HAEMATOLOGICA
- Transcriptional Regulation of BACE1 by NFAT3 Leads to Enhanced Amyloidogenic Processing
- (2015) Zhengrong Mei et al. NEUROCHEMICAL RESEARCH
- ENCODE data at the ENCODE portal
- (2015) Cricket A. Sloan et al. NUCLEIC ACIDS RESEARCH
- Association study of functional polymorphisms in interleukins and interleukin receptors genes: IL1A, IL1B, IL1RN, IL6, IL6R, IL10, IL10RA and TGFB1 in schizophrenia in Polish population
- (2015) Pawel Kapelski et al. SCHIZOPHRENIA RESEARCH
- Meta-analysis of incidence and risk of peripheral neuropathy associated with intravenous bortezomib
- (2015) Ling Peng et al. SUPPORTIVE CARE IN CANCER
- European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
- (2015) E. Terpos et al. HAEMATOLOGICA
- Endothelin-1 Gene Polymorphisms Influence Cerebrospinal Fluid Endothelin-1 Levels Following Aneurysmal Subarachnoid Hemorrhage
- (2014) M. J. Gallek et al. Biological Research for Nursing
- Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes
- (2014) G. Y. Lee et al. CANCER RESEARCH
- Endothelin A Receptor/ -Arrestin Signaling to the Wnt Pathway Renders Ovarian Cancer Cells Resistant to Chemotherapy
- (2014) L. Rosano et al. CANCER RESEARCH
- MED20 mutation associated with infantile basal ganglia degeneration and brain atrophy
- (2014) Julia Vodopiutz et al. EUROPEAN JOURNAL OF PEDIATRICS
- Global Epigenetic Regulation of MicroRNAs in Multiple Myeloma
- (2014) Wenjing Zhang et al. PLoS One
- Myeloma Is Characterized by Stage-Specific Alterations in DNA Methylation That Occur Early during Myelomagenesis
- (2013) C. J. Heuck et al. JOURNAL OF IMMUNOLOGY
- Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk
- (2013) Daniel Chubb et al. NATURE GENETICS
- Synergistic effect of panobinostat and bortezomib on chemoresistant acute myelogenous leukemia cells via AKT and NF-κB pathways
- (2012) Xue-Jie Jiang et al. CANCER LETTERS
- Distinct Activation Properties of the Nuclear Factor of Activated T-cells (NFAT) Isoforms NFATc3 and NFATc4 in Neurons
- (2012) Jason D. Ulrich et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Permissive role of endothelin receptors in tumor metastasis
- (2012) Neveen Said et al. LIFE SCIENCES
- Similar expression to FGF (Sef) reduces endometrial adenocarcinoma cells proliferation via inhibiting fibroblast growth factor 2-mediated MAPK/ERK signaling pathway
- (2011) Hui Zhang et al. GYNECOLOGIC ONCOLOGY
- Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patients
- (2011) S. L. Corthals et al. HAEMATOLOGICA
- Genetic variation associated with bortezomib-induced peripheral neuropathy
- (2011) Reyna Favis et al. Pharmacogenetics and Genomics
- Bleeding and Thrombosis in Multiple Myeloma and Related Plasma Cell Disorders
- (2011) Antonio Coppola et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial
- (2010) Annemiek Broyl et al. LANCET ONCOLOGY
- Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues
- (2010) Michel Delforge et al. LANCET ONCOLOGY
- A map of human genome variation from population-scale sequencing
- (2010) Richard M. Durbin et al. NATURE
- Cognitive Decline in Alzheimer's Disease Is Associated with Selective Changes in Calcineurin/NFAT Signaling
- (2009) H. M. Abdul et al. JOURNAL OF NEUROSCIENCE
- A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies
- (2009) Bryan N. Howie et al. PLoS Genetics
- Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival
- (2008) Brian Van Ness et al. BMC Medicine
- IL-17RD (Sef or IL-17RLM) interacts with IL-17 receptor and mediates IL-17 signaling
- (2008) Zhili Rong et al. CELL RESEARCH
- Activation of the nuclear factor of activated T-cells (NFAT) mediates upregulation of CCR2 chemokine receptors in dorsal root ganglion (DRG) neurons: A possible mechanism for activity-dependent transcription in DRG neurons in association with neuropathic pain
- (2007) Hosung Jung et al. MOLECULAR AND CELLULAR NEUROSCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started